Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Alabas OA, Mason KJ, Yiu ZZN, Hampton PJ, Reynolds NJ, Owen CM, Bewley A, Laws PM, Warren RB, Lunt M, Smith CH, Griffiths CEM; BADBIR Study Group. Alabas OA, et al. Among authors: bewley a. Br J Dermatol. 2023 Apr 20;188(5):618-627. doi: 10.1093/bjd/ljad004. Br J Dermatol. 2023. PMID: 36763783
Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials.
Piraccini BM, Ohyama M, Craiglow B, Bewley A, Ding Y, Chen YF, Dutronc Y, Pierce E, Durand F, Mostaghimi A. Piraccini BM, et al. Among authors: bewley a. J Dermatolog Treat. 2023 Dec;34(1):2227299. doi: 10.1080/09546634.2023.2227299. J Dermatolog Treat. 2023. PMID: 37381691 Free article.
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis.
Halioua B, Caillet G, Taieb C, Bewley A, Snel-Prentø A, Praestegaard M, Armstrong A, Pinter A. Halioua B, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):e326-e328. doi: 10.1111/jdv.19600. Epub 2023 Nov 21. J Eur Acad Dermatol Venereol. 2024. PMID: 37907283 No abstract available.
Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne.
Chernyshov PV, Sampogna F, Raimondi G, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, Pustišek N, Bettoli V, Koumaki D, Bewley AP, Dreno B, Tomas-Aragones L. Chernyshov PV, et al. Among authors: bewley ap. JAAD Int. 2024 Mar 25;16:9-17. doi: 10.1016/j.jdin.2024.03.007. eCollection 2024 Sep. JAAD Int. 2024. PMID: 38764481 Free PMC article.
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S, Pereira MP, Zeidler C, Legat FJ, Misery L, Lönndahl L, Bewley AP, Brenaut E, Bobko S, Elberling J, Evers AWM, Garcovich S, Gieler U, Gonçalo M, Kupfer J, Lambert J, Lvov A, Metz M, Michenko A, Papadavid E, Reich A, Savk E, Schneider G, Schut C, Serra-Baldrich E, Ständer HF, Szepietowski JC, Wallengren J, Weisshaar E, Augustin M. Ständer S, et al. Among authors: bewley ap. J Eur Acad Dermatol Venereol. 2024 May 13. doi: 10.1111/jdv.20102. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38738586
Efficacy of antipsychotics in delusional infestation.
Tang PK, Lepping P, Lepping SG, Noorthoorn EO, Squire SB, Mohandas P, Bewley A. Tang PK, et al. Among authors: bewley a. J Eur Acad Dermatol Venereol. 2024 May 10. doi: 10.1111/jdv.20081. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38727630
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
Dirr MA, Ahmed A, Schlessinger DI, Haq M, Shi V, Koza E, Ma M, Christensen RE, Ibrahim SA, Schmitt J, Johannsen L, Asai Y, Baldwin HE, Berardesca E, Berman B, Vieira AC, Chien AL, Cohen DE, Del Rosso JQ, Dosal J, Drake LA, Feldman SR, Fleischer AB Jr, Friedman A, Graber E, Harper JC, Helfrich YR, Jemec GB, Johnson SM, Katta R, Lio P, Maier LE, Martin G, Nagler AR, Neuhaus IM, Palamar M, Parish LC, Rosen T, Shumack SP, Solomon JA, Tanghetti EA, Webster GF, Weinkle A, Weiss JS, Wladis EJ, Maher IA, Sobanko JF, Cartee TV, Cahn BA, Alam M; IMPROVED-COS Rosacea Working Group; Kang BY, Iyengar S, Anvery N, Alpsoy E, Bewley A, Dessinioti C, Egeberg A, Engin B, Gollnick HPM, Ioannides D, Kim HS, Lazaridou E, Li J, Lim HG, Micali G, de Oliveira CMM, Noguera-Morel L, Parodi A, Reinholz M, Suh DH, Sun Q, van Zuuren EJ, Wollina U, Zhou Y, Zip C, Poon E, Pearlman R. Dirr MA, et al. Among authors: bewley a. JAMA Dermatol. 2024 Apr 24. doi: 10.1001/jamadermatol.2024.0636. Online ahead of print. JAMA Dermatol. 2024. PMID: 38656294
293 results